Skin Therapy Letter HOME
Written for dermatologists by dermatologists. Indexed by the US National Library of Medicine.
Skin Information
NETWORK
Skin Therapy Letter About STL Subscribe Today SkinCareGuide Network Site Map
CUSTOM DERMATOLOGY SEARCH:
Loading

Skin Therapy Letter: Volume 13 - 2008

  Number 8 • December 2008   |  Download PDF

IL-12/IL-23 Inhibitors: The Advantages and Disadvantages of this Novel Approach for the Treatment of Psoriasis
B. L. Bartlett, MD1; M. N. Moody, MPH2; S. K. Tyring, MD, PhD, MBA1,3
1. Center for Clinical Studies, Houston, TX, USA
2. The University of Texas Medical School at Houston, Houston, TX, USA
3. Department of Dermatology, University of Texas Health Sciences Center, Houston, TX, USA

The Role of Cosmeceuticals in Antiaging Therapy
J. K. Rivers, MD, FRCPC
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC
Pacific Dermaesthetics, Vancouver, BC

Update on Drugs and Drug News: December 2008

Top

  Number 7 • September 2008   |  Download PDF

Current Concepts in the Treatment of Recurrent Aphthous Stomatitis
A. Altenburg, MD; C. C. Zouboulis, MD
Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany

Antioxidants Used in Skin Care Formulations
I. Bogdan Allemann, MD; L. Baumann, MD
Cosmetic Medicine and Research Institute, Miller School of Medicine, University of Miami, Miami Beach, FL, USA

Update on Drugs and Drug News: September 2008

Top

  Number 6 • July - August 2008   |  Download PDF

Botulinum Toxin Products Overview
A. Carruthers, MD, FRCPC1; J. Carruthers, MD, FRCS(C), FRC(Ophth)2
1. Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada
2. Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada

Update on Sunscreens
R. Bissonnette, MD, FRCPC
Innovaderm Research, Montreal, QC, Canada

Update on Drugs and Drug News: July-August 2008

Top

  Number 5 • June 2008   |  Download PDF

The A-B-C-Ds of Sensible Sun Protection
B. A. Gilchrest, MD
Department of Dermatology, Boston University School of Medicine, Boston, MA, USA

Novel Topical Drug Delivery Systems and Their Potential Use in Acne Vulgaris
M. Taglietti, MD1; C. N. Hawkins, BScH2; J. Rao, MD, FRCPC3
1. Forest Research Institute, Jersey City, NJ, USA
2. Queen’s University, Kingston, ON, Canada
3. Division of Dermatology, University of Alberta, Edmonton, AB, Canada

Update on Drugs and Drug News - May 2008

Top

  Number 4 • May 2008   |  Download PDF

Systemic and Light Therapies for the Management of Childhood Psoriasis: Part II
K. M. Cordoro, MD
Department of Dermatology, University of California, San Francisco, CA, USA

The Role of the Dermatologist in Identification and Treatment of the Early Stages of Psoriatic Arthritis
I. Landells, MD, FRCPC1,2; C. MacCallum, BSc Pharm1; M. Khraishi, MD, FRCPC1,2
1. Memorial University of Newfoundland Faculty of Medicine, St. John’s, NL, Canada
2. Nexus Clinical Research, St. John’s, NL, Canada

Update on Drugs and Drug News - May 2008

Top

  Number 3 • April 2008   |  Download PDF

Topical Therapy for the Management of Childhood Psoriasis: Part I
K. M. Cordoro, MD
Department of Dermatology, University of California, San Francisco, CA, USA

Advances in Pemphigus Therapy
V. Prajapati; P. R. Mydlarski MD, FRCPC
Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada

Update on Drugs and Drug News - April 2008

Top

  Number 2 • March 2008   |  Download PDF

An Update on New and Emerging Options for the Treatment of Vitiligo
B. H. Mahmoud, MD, PhD; C. L. Hexsel, MD; I. H. Hamzavi, MD
Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA

Drug Treatments for Skin Disease Introduced in 2007

Update on Drugs and Drug News - March 2008

Top

  Number 1 • February 2008   |  Download PDF

Psoriasis as the Marker of Underlying Systemic Disease
A. S. Kourosh, BS1; A. Miner, BS1; A. Menter, MD1,2
1The University of Texas Southwestern Medical School, Dallas, TX, USA
2Division of Dermatology, Baylor University Medical Center, Dallas TX, USA

Novel Agents for Intractable Itch
C. B. Lynde1; J. N. Kraft, MD2; C. W. Lynde, MD, FRCPC1
1Faculty of Medicine, University of Toronto, Toronto, ON, Canada
2Division of Dermatology, Sunnybrook Hospital, University of Toronto, Toronto, ON, Canada

Update on Drugs and Drug News - February 2008

Top